Recent News

UF’s EPI is partnering with Gainesville-based tech company SurfPlasma, Inc. to test a new device’s ability to kill pathogens — even the celestial kinds.

UF researchers find first known instance of Yunnan orbivirus in North America from postmortem tests on tissues from a farmed white-tailed deer in Florida.

Recent work contributed to by UF mathematician Burton Singer seeks to estimate how COVID-19 vaccination campaigns will affect the future trajectory of the pandemic in the US.

An editorial by UF professors, published in the American Journal of Public Health, casts a spotlight on the plight of guest agricultural workers during the pandemic.

New research published in Science looks back at how COVID-19 spread over time throughout Brazil, to create a pandemic hotspot.

New research by UF investigators on Salmonella infections in Florida highlights the influence of seasons, geography and age upon transmission patterns. The team also developed new AI-based methods for detecting outbreaks and linking cases to environmental or food sources.

Two new studies advance a potentially groundbreaking transmission-blocking malaria vaccine. UF researcher Rhoel Dinglasan's approach is completely different: Immunizing mosquitoes with malaria transmission-blocking antibodies produced in people.

UF investigators participate in the first study to determine that the CoronaVac vaccine is 50% effective at preventing COVID-19 in Manaus, Brazil where the P.1 variant is widespread.

Coronaviruses common to animals may ‘spillover’ into people more frequently than once thought, according to new research from UF and Haitian investigators.

A malaria vaccine designed by UF professor Rhoel Dinglasan is expected to advance to phase 1 clinical trials, thanks to new funding. The vaccine is designed differently from all others: It immunizes mosquitoes via people.